Skip to main content
. 2014 Feb 16;201:7–12. doi: 10.1016/j.jviromet.2014.02.001

Fig. 4.

Fig. 4

High-throughput analysis of patient serum. (A) Serum of CHIKV infected patients, dengue virus infected patients or healthy controls was serially diluted, incubated with CHIKV Env pseudotyped vector particles and analyzed for its neutralizing activity by detection of relative luciferase activities. The luciferase activity is shown in percentage, relative to untreated control. (B) Serum of CHIKV infected patients, dengue virus infected patients or healthy controls was serially diluted, incubated with VSV-G pseudotyped vector particles and analyzed for its neutralizing activity by detection of relative luciferase activities. The luciferase activity is shown in percentage, relative to untreated control. The values represent mean values of triplicate measurements.